Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Aspire Biopharma Holdings, Inc. (ASBP) Cash Flow from Investing Activities data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.06M |
|
$-1.27M |
|
$0.09M |
|
$-0.03M |
|
$2.74M |
|
$-2.68M |
|
$1.41M |
|
$-1.27M |
|
$-1.27M |
|
$-1.27M |
|
$-1.27M |
|
$-1.27M |
|
$-1.27M |
|
$-2.68M |
|
$-2.68M |
|
1.04M |
|
1.04M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$13.47M |
|
-- |
|
$0.07M |
|
$13.54M |
|
$1.69M |
|
-- |
|
$0.10M |
|
$1.78M |
|
$11.76M |
|
$11.76M |
|
$11.76M |
|
1.29M |
|
| Cash Flow Statement Financials | |
$-5.15M |
|
|
Cash Flow from Investing Activities |
-- |
$16.32M |
|
$1.00M |
|
$12.17M |
|
$11.16M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-47.68% |
|
-4244.14% |
|
-4244.14% |
|
-- |
|
-2009.61% |
|
-2009.61% |
|
$-5.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.32 |
|
-- |
|
-- |
|
-10.79% |
|
-10.79% |
|
-9.37% |
|
-10.79% |
|
$9.08 |
|
$-4.97 |
|
$-4.97 |
|